PARALLEL CONTRACTILE SIGNAL-TRANSDUCTION PATHWAYS ACTIVATED BY RECEPTORS FOR THROMBIN AND EPIDERMAL GROWTH FACTOR-UROGASTRONE IN GUINEA-PIGGASTRIC SMOOTH-MUSCLE - BLOCKADE BY INHIBITORS OF MITOGEN-ACTIVATED PROTEIN KINASE-KINASE AND PHOSPHATIDYL-INOSITOL 3'-KINASE
Xl. Zheng et al., PARALLEL CONTRACTILE SIGNAL-TRANSDUCTION PATHWAYS ACTIVATED BY RECEPTORS FOR THROMBIN AND EPIDERMAL GROWTH FACTOR-UROGASTRONE IN GUINEA-PIGGASTRIC SMOOTH-MUSCLE - BLOCKADE BY INHIBITORS OF MITOGEN-ACTIVATED PROTEIN KINASE-KINASE AND PHOSPHATIDYL-INOSITOL 3'-KINASE, The Journal of pharmacology and experimental therapeutics, 285(1), 1998, pp. 325-334
Using a guinea pig gastric longitudinal smooth muscle preparation, we
have compared the contractile signaling pathways triggered by the thro
mbin receptor-activating peptide, TFLLR-NH2 (TF) and by epidermal grow
th factor-urogastrone (EGF). In addition to inhibitors of tyrosine kin
ase [tyrphostin 47/AG213, genistein and the src-selective inhibitor CP
118,556/PP1], cyclooxygenase (indomethacin, INDO) and diacylglycerol l
ipase (U57, 908), we also used the signal pathway probe inhibitors of
mitogen-activated protein-kinase-kinase (MEK:PD98059), phosphatidylino
sitol 3'-kinase [Pl3K: Wortmannin (WM) and LY294002], protein kinase C
[PKC: GF109203X(GF)], and of the EGF-receptor kinase (PD153035), We f
ound that in addition to the inhibition of both TF and EGF-stimulated
contractions by the inhibitors of tyrosine kinase, cyclooxygenase and
diacylglycerol lipase, the actions of TF and EGF were also attenuated
by PD98059, WM/LY294002 and GF. However, PD153035 blocked only EGF-tri
ggered contractions. The contractile actions of both TF and EGF were d
ependent on extracellular calcium. In contrast, the contractile action
of arachidonic acid, via a presumed cyclooxygenase product that media
ted the contractions caused by both TF and EGF, was not blocked by any
of the signal pathway probe inhibitors. The contractile actions of bo
th TF and EGF were accompanied by increases in tissue phosphotyrosyl p
roteins and an increase in tissue c-src kinase activity. We conclude t
hat protease-activated receptor no. 1-(thrombin receptor) mediated con
tractions in the logitudial muscle, like EGF receptor-activated respon
ses, require the influx of extracellular calcium and use parallel sign
al pathways upstream of the cyclooxygenase step, involving MEK, Pl3K,
kinase C and possibly cellular src. The TF-induced response did not in
volve trans-activation of the EGF receptor kinase; but the converse (i
.e., trans-activation of protease-activated receptor no. 1 (thrombin r
eceptor) by the EGF receptor kinase) could not be ruled out.